ArticleNature2025
Cooperative nutrient scavenging is an evolutionary advantage in cancer.
Abstract read
In one paragraph
Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Translocation-induced enhancer rewiring reveals cryptic oncogenic circuits in multiple myeloma.Science advances · 2026Article
- Article
- Regional HNSCC metabolomics reveals widespread changes to one-carbon metabolism and S-adenosylmethionine metabolism across tumour core, tumour edge and adjacent non-tumour tissues.British journal of cancer · 2026Article
- Therapy-resistant lymphomas may want nucleotides, but they just need to grow.The Journal of clinical investigation · 2026Article
- Targeting the cancer metabolism-immunity interface: update and perspectives.Experimental hematology & oncology · 2026Review
- Fatty Acid Metabolism in Health and Cancer: From Fundamental Mechanisms to Therapeutic Application.MedComm · 2026Review
- LDAcoop: Integrating non-linear population dynamics into the analysis of clonogenic growth in vitro.Molecular oncology · 2026Article
- Stress-responsive membrane proteins as execution nodes of tumor cell adaptation to microenvironmental stress.Oncogene · 2026Review
- Article
- Tumor-Targeted Delivery Therapy Based on PLGA Nanoparticles.Journal of functional biomaterials · 2026Review
- Reprogramming of nitrogen metabolism in tumors: mechanisms and therapeutic implications.Amino acids · 2026Review
- Simulating Cancer Recurrence Patterns From Post-Treatment Viable Tumor Burden Distributions.JCO clinical cancer informatics · 2026Article
- Ultrasound-Responsive Engineered Bacteria for Targeted Cancer Therapy: Strategies, Mechanisms, and Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- A CHKA-PML autophagy checkpoint enables tumors to evade glutamine starvation.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Beyond exercise and appetite: The expanding biology and therapeutic potential of N-lactoyl-phenylalanine.The Journal of pharmacology and experimental therapeutics · 2026Review
- Strength through diversity: how cancers thrive when clones cooperate.Molecular oncology · 2026Review
- Integrative pan-cancer analysis of dipeptidyl peptidase 4 with clinical andFrontiers in immunology · 2026Article
- From benchside avatars to bedside breakthroughs: Patient-derived organoids in the new era of cancer immunotherapy.Translational oncology · 2026Review
- The Quartet of Core Oncogenic Drivers in Neuroendocrine Prostate Cancer: Multi-Omics Dataset Integration to Forge a Translational Link Between Biology and Precision Therapy.International journal of biological sciences · 2026Review
- Identification of KKL-35 as a Novel Carnosine Dipeptidase 2 (CNDP2) Inhibitor by In Silico Screening.Molecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Gizem Guzelsoy *Center for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, USA.ORCID 0000-0002-6227-3501
Setiembre D Elorza *Center for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, USA.
Manon RosCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, USA.ORCID 0000-0001-7878-3613
Logan T SchachtnerCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, USA.
Makiko HayashiDepartment of Pathology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA.
Spencer Hobson-GutierrezCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, USA.
Parker RundstromCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, USA.
Julia S BrunnerCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-3195-147X
Ray PillaiDepartment of Pathology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA.ORCID 0000-0002-8335-3463
William E WalkowiczChemitope Glycopeptide, Brooklyn, NY, USA.
Lydia W S FinleyCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-4023-7574
Maxime DeforetSorbonne Université, CNRS, Institut de Biologie Paris-Seine (IBPS), Laboratoire Jean Perrin (LJP), Paris, France.
Thales PapagiannakopoulosDepartment of Pathology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA.ORCID 0000-0002-2251-1624
Carlos Carmona-FontaineCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, USA. cf97@nyu.edu.ORCID 0000-0002-5238-6852
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MVaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1MTRAINING PROGRAM IN DEVELOPMENTAL GENETICS.T32HD007520 · NICHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TREISMAN, JESSICA E · 1999 to 2023
$3.9MDecoding the fundamental mechanisms of tumor emergence and evolutionDP2CA250005 · NCI · NEW YORK UNIVERSITY · PI CARMONA-FONTAINE, CARLOS · 2019 to 2019
$2.4MNCI NIH HHS DP2 CA250005NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016087NICHD NIH HHS T32 HD007520
Abstract
The survival of malignant cells within tumours is often seen as depending on ruthless competition for nutrients and other resources
Indexed as
Biological EvolutionNeoplasmsNutrientsAmino AcidsAminopeptidasesAnimalsCell Line, TumorCell ProliferationCell SurvivalFemaleHumansHydrolysisMiceMice, Inbred C57BLOligopeptidesTumor MicroenvironmentAmino AcidsAminopeptidasesNutrientsOligopeptides
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.